SCOTUS agrees to hear Amgen revival bid

07-11-2022

Staff Writer

SCOTUS agrees to hear Amgen revival bid

Marlon Trottmann / Shutterstock.com

The dispute centres on a section of the Patent Act concerning 'enablement' | The US government had urged the court to deny the petition.


SCOTUS, US Supreme Court, patent infringement, patent enablement, Sanofi, Regeneron, Amgen, innovation, US, Americas, big pharma, generics,

LSIPR